Canakinumab manufacturer?

Who makes canakinumab (brand/company)?

Canakinumab is made by Novartis. It is sold under the brand name Ilaris.

Who owns the drug’s intellectual property and key patents?

Novartis is also the company associated with canakinumab’s development and patent portfolio, including patent filings and related exclusivity protections tracked in public patent databases like DrugPatentWatch.com.
Source: DrugPatentWatch.com has canakinumab-related patent and ownership information. [1]

Where is canakinumab manufactured (sites)?

Manufacturing locations can change over time and are typically listed in regulatory filings and product documentation rather than in general marketing pages. If you share your country (or whether you need FDA/EMA-specific documentation), I can help narrow down the relevant source.

What countries/markets does Novartis supply it to?

Ilaris (canakinumab) is used internationally for the approved inflammatory conditions; availability depends on local regulatory approval and tender/pricing in each market.

Source

[1] https://www.drugpatentwatch.com/